| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | H1-8 TNRC18 BRIP1 CEBPB NANOGP1 ATRX DPPA4 HPF1 H1-3 SMARCB1 MLLT1 MSL1 ASXL2 NCAPH TOP2B MSL2 | 4.05e-09 | 739 | 70 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.63e-05 | 167 | 70 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | SUMO binding | 3.84e-05 | 19 | 70 | 3 | GO:0032183 | |
| GeneOntologyMolecularFunction | SUMO polymer binding | 1.80e-04 | 6 | 70 | 2 | GO:0032184 | |
| GeneOntologyMolecularFunction | histone binding | 3.33e-04 | 265 | 70 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | PHF2 CASP8AP2 NRIP1 NANOGP1 ANK3 HPF1 LPIN2 SMARCB1 MSL1 ZNF598 USP16 TRDN | 6.49e-04 | 1160 | 70 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 6.53e-04 | 11 | 70 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | PHF2 CASP8AP2 NRIP1 NANOGP1 ANK3 HPF1 LPIN2 SMARCB1 MSL1 ZNF598 USP16 TRDN MSL2 | 7.71e-04 | 1356 | 70 | 13 | GO:0060090 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.82e-04 | 206 | 70 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | RNA polymerase I transcription regulatory region sequence-specific DNA binding | 9.22e-04 | 13 | 70 | 2 | GO:0001163 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 9.50e-04 | 55 | 70 | 3 | GO:0001046 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 1.07e-03 | 128 | 70 | 4 | GO:0032182 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.68e-03 | 67 | 70 | 3 | GO:0031492 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.21e-03 | 20 | 70 | 2 | GO:0035259 | |
| GeneOntologyBiologicalProcess | cell division | SAMD9L BRIP1 MIS18BP1 NANOGP1 ANK3 VPS4A CNTRL FGF7 USP39 NCAPH USP16 | 1.86e-05 | 697 | 69 | 11 | GO:0051301 |
| GeneOntologyBiologicalProcess | chromatin remodeling | PHF2 H1-8 ARID4B ATRX HPF1 H1-3 SMARCB1 MSL1 USP16 PRDM2 MSL2 | 3.26e-05 | 741 | 69 | 11 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of cell communication by electrical coupling | 3.30e-05 | 3 | 69 | 2 | GO:0010650 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | PHF2 H1-8 ARID4B ATRX UBTFL1 HPF1 H1-3 SMARCB1 MSL1 USP16 PRDM2 MSL2 | 1.07e-04 | 999 | 69 | 12 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromosome organization involved in meiotic cell cycle | 1.17e-04 | 75 | 69 | 4 | GO:0070192 | |
| GeneOntologyCellularComponent | condensed chromosome | 8.19e-05 | 307 | 71 | 7 | GO:0000793 | |
| GeneOntologyCellularComponent | chromatin | ANKRD31 NRIP1 H1-8 BBX CEBPB NANOGP1 ARID4B ATRX HPF1 H1-3 SMARCB1 MSL1 TOP2B AFF4 MSL2 | 1.10e-04 | 1480 | 71 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | MSL complex | 1.13e-04 | 5 | 71 | 2 | GO:0072487 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NRIP1 BRIP1 MIS18BP1 CEBPB ARID4B CLMN VPS4A PES1 SMARCB1 MLLT1 ASXL2 USP39 AFF4 | 6.68e-04 | 1377 | 71 | 13 | GO:0140513 |
| Domain | Znf_UBP | 1.78e-05 | 14 | 70 | 3 | IPR001607 | |
| Domain | zf-UBP | 1.78e-05 | 14 | 70 | 3 | PF02148 | |
| Domain | ZF_UBP | 1.78e-05 | 14 | 70 | 3 | PS50271 | |
| Domain | SAM_DOMAIN | 2.85e-05 | 95 | 70 | 5 | PS50105 | |
| Domain | SAM | 3.16e-05 | 97 | 70 | 5 | IPR001660 | |
| Domain | - | 4.83e-05 | 106 | 70 | 5 | 1.10.150.50 | |
| Domain | SAM/pointed | 7.74e-05 | 117 | 70 | 5 | IPR013761 | |
| Domain | Liprin | 2.06e-04 | 6 | 70 | 2 | IPR029515 | |
| Domain | - | 2.68e-04 | 449 | 70 | 8 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 3.11e-04 | 459 | 70 | 8 | IPR013083 | |
| Domain | SAM | 3.33e-04 | 88 | 70 | 4 | SM00454 | |
| Domain | SAM_2 | 5.59e-04 | 43 | 70 | 3 | PF07647 | |
| Domain | ZnF_UBP | 7.45e-04 | 11 | 70 | 2 | SM00290 | |
| Domain | H15 | 1.05e-03 | 13 | 70 | 2 | SM00526 | |
| Domain | Linker_histone | 1.05e-03 | 13 | 70 | 2 | PF00538 | |
| Domain | H15 | 1.05e-03 | 13 | 70 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 1.22e-03 | 14 | 70 | 2 | IPR005818 | |
| Domain | SAM_1 | 2.12e-03 | 68 | 70 | 3 | PF00536 | |
| Domain | USP_1 | 2.31e-03 | 70 | 70 | 3 | PS00972 | |
| Domain | UCH | 2.40e-03 | 71 | 70 | 3 | PF00443 | |
| Domain | USP_2 | 2.40e-03 | 71 | 70 | 3 | PS00973 | |
| Domain | USP_3 | 2.50e-03 | 72 | 70 | 3 | PS50235 | |
| Domain | USP_dom | 2.50e-03 | 72 | 70 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 2.50e-03 | 72 | 70 | 3 | IPR001394 | |
| Domain | - | 2.52e-03 | 20 | 70 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 2.78e-03 | 21 | 70 | 2 | IPR003594 | |
| Domain | ZF_PHD_2 | 5.46e-03 | 95 | 70 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 5.62e-03 | 96 | 70 | 3 | PS01359 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PHF2 BRIP1 MIS18BP1 BBX ARID4B ATRX VEZF1 PES1 SMARCB1 MSL1 USP39 HERC2 TOP2B AFF4 PRDM2 NCBP3 | 8.24e-14 | 608 | 71 | 16 | 36089195 |
| Pubmed | STIM2 TNRC18 ILF3 BBX ATRX VEZF1 SACS RSL1D1 PPFIA2 PPFIA1 PCLO CNTRL PES1 H1-3 MLLT1 MSL1 NCAPH TRDN ERBIN MNDA TOP2B | 6.09e-13 | 1442 | 71 | 21 | 35575683 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PHF2 CASP8AP2 ILF3 BBX CEBPB ARID4B ATRX VEZF1 RSL1D1 SMARCB1 MLLT1 MSL1 ASXL2 USP39 TOP2B PRDM2 MSL2 | 7.01e-10 | 1294 | 71 | 17 | 30804502 |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 3.62e-08 | 92 | 71 | 6 | 15840729 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PHF2 BRIP1 ILF3 BBX ARID4B ATRX VEZF1 RSL1D1 MLLT1 MSL1 TOP2B AFF4 NCBP3 | 6.13e-08 | 954 | 71 | 13 | 36373674 |
| Pubmed | CASP8AP2 STIM2 ILF3 ANK3 ATRX SACS RSL1D1 CLMN PPFIA1 PES1 HERC2 USP16 ERBIN TOP2B NCBP3 | 2.60e-07 | 1487 | 71 | 15 | 33957083 | |
| Pubmed | PHF2 TNRC18 ILF3 CEBPB VEZF1 RSL1D1 PES1 SMARCB1 ASXL2 USP39 MNDA TOP2B PRDM2 | 3.23e-07 | 1103 | 71 | 13 | 34189442 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 6.12e-07 | 148 | 71 | 6 | 32538781 | |
| Pubmed | PHF2 BBX ARID4B ATRX VEZF1 RSL1D1 PES1 SMARCB1 MLLT1 MSL1 ASXL2 HERC2 ERBIN PRDM2 | 9.83e-07 | 1429 | 71 | 14 | 35140242 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.40e-06 | 533 | 71 | 9 | 30554943 | |
| Pubmed | PHF2 BBX CEBPB ATRX VEZF1 PPFIA1 PES1 MLLT1 MSL1 HERC2 ZNF598 ERBIN AFF4 MSL2 | 1.70e-06 | 1497 | 71 | 14 | 31527615 | |
| Pubmed | USP45 ANK3 ATRX RSL1D1 CLMN PPFIA1 CNTRL ASXL2 ERBIN ZFP37 AFF4 PRDM2 | 1.86e-06 | 1084 | 71 | 12 | 11544199 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ILF3 ATRX RSL1D1 CLMN PES1 ZNF598 NCAPH USP16 ERBIN TOP2B AFF4 | 2.91e-06 | 934 | 71 | 11 | 33916271 |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15707977 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12698291 | ||
| Pubmed | 5.21e-06 | 469 | 71 | 8 | 27634302 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 5.40e-06 | 56 | 71 | 4 | 26919559 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.72e-06 | 475 | 71 | 8 | 31040226 | |
| Pubmed | 6.41e-06 | 222 | 71 | 6 | 37071664 | ||
| Pubmed | 6.76e-06 | 486 | 71 | 8 | 20936779 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 8.04e-06 | 231 | 71 | 6 | 16452087 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PHF2 ILF3 BBX ZC2HC1A VEZF1 SACS PES1 SMARCB1 USP39 TOP2B AFF4 | 1.17e-05 | 1082 | 71 | 11 | 38697112 |
| Pubmed | KGF promotes integrin alpha5 expression through CCAAT/enhancer-binding protein-beta. | 1.23e-05 | 3 | 71 | 2 | 17596295 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 23084835 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 25305019 | ||
| Pubmed | Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1. | 1.23e-05 | 3 | 71 | 2 | 18474607 | |
| Pubmed | 1.40e-05 | 149 | 71 | 5 | 25184681 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MIS18BP1 ILF3 ZC2HC1A RSL1D1 VPS4A PES1 DDX60L HERC2 NCAPH USP16 ERBIN TOP2B | 1.75e-05 | 1353 | 71 | 12 | 29467282 |
| Pubmed | PHF2 ILF3 VEZF1 RSL1D1 RALBP1 PPFIA1 PES1 SMARCB1 MSL1 HERC2 AFF4 NCBP3 | 2.00e-05 | 1371 | 71 | 12 | 36244648 | |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 2.29e-05 | 165 | 71 | 5 | 16107646 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.43e-05 | 281 | 71 | 6 | 28706196 | |
| Pubmed | Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4. | 2.46e-05 | 4 | 71 | 2 | 25282333 | |
| Pubmed | Disruption of the MSL complex inhibits tumour maintenance by exacerbating chromosomal instability. | 2.46e-05 | 4 | 71 | 2 | 33837287 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 21565293 | ||
| Pubmed | HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold. | 2.46e-05 | 4 | 71 | 2 | 23251033 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.78e-05 | 774 | 71 | 9 | 15302935 | |
| Pubmed | 2.86e-05 | 777 | 71 | 9 | 35844135 | ||
| Pubmed | ILF3 ZC2HC1A ANK3 SACS PACSIN1 CLMN PPFIA2 PPFIA1 PCLO H1-3 CNKSR2 ERBIN | 3.04e-05 | 1431 | 71 | 12 | 37142655 | |
| Pubmed | 3.32e-05 | 441 | 71 | 7 | 31239290 | ||
| Pubmed | 3.52e-05 | 31 | 71 | 3 | 15217342 | ||
| Pubmed | CASP8AP2 MIS18BP1 ILF3 CEBPB ATRX PES1 SMARCB1 USP39 NCAPH TOP2B | 3.92e-05 | 1014 | 71 | 10 | 32416067 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 11882656 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 15096481 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 19013515 | ||
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 5.09e-05 | 35 | 71 | 3 | 37381005 | |
| Pubmed | NRIP1 ANK3 ATRX SACS RSL1D1 RALBP1 HPF1 HERC2 REPS2 USP16 AFF4 | 5.62e-05 | 1285 | 71 | 11 | 35914814 | |
| Pubmed | 5.68e-05 | 655 | 71 | 8 | 35819319 | ||
| Pubmed | 5.99e-05 | 660 | 71 | 8 | 32780723 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 6.10e-05 | 857 | 71 | 9 | 25609649 | |
| Pubmed | A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. | 6.13e-05 | 6 | 71 | 2 | 10619021 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 37062716 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 34878123 | ||
| Pubmed | Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins. | 6.13e-05 | 6 | 71 | 2 | 21618221 | |
| Pubmed | Regulation of complex formation of POB1/epsin/adaptor protein complex 2 by mitotic phosphorylation. | 6.13e-05 | 6 | 71 | 2 | 10764745 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.05e-05 | 497 | 71 | 7 | 36774506 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PHF2 NRIP1 ILF3 RSL1D1 PES1 HPF1 H1-3 SMARCB1 NCAPH USP16 TOP2B | 7.05e-05 | 1318 | 71 | 11 | 30463901 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.12e-05 | 341 | 71 | 6 | 32971831 | |
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 8.22e-05 | 41 | 71 | 3 | 15561718 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 34931676 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 9422736 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 19843671 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 16543150 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 20960050 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 20111005 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 31631027 | ||
| Pubmed | The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. | 8.57e-05 | 7 | 71 | 2 | 15856011 | |
| Pubmed | Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting. | 8.57e-05 | 7 | 71 | 2 | 11931740 | |
| Pubmed | 1.02e-04 | 713 | 71 | 8 | 29802200 | ||
| Pubmed | 1.09e-04 | 45 | 71 | 3 | 33596420 | ||
| Pubmed | Histone h1 depletion impairs embryonic stem cell differentiation. | 1.14e-04 | 8 | 71 | 2 | 22589736 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 21873227 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 12775724 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 22483617 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ILF3 RSL1D1 SMARCB1 MSL1 ASXL2 USP39 HERC2 CFAP97 TOP2B MSL2 | 1.15e-04 | 1155 | 71 | 10 | 20360068 |
| Pubmed | 1.20e-04 | 234 | 71 | 5 | 36243803 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PHF2 ILF3 ATRX RSL1D1 VPS4A PCLO PES1 USP39 NCAPH TOP2B PRDM2 | 1.41e-04 | 1425 | 71 | 11 | 30948266 |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 12923177 | ||
| Pubmed | Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1. | 1.47e-04 | 9 | 71 | 2 | 24412544 | |
| Pubmed | Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting. | 1.47e-04 | 9 | 71 | 2 | 12629171 | |
| Pubmed | 1.48e-04 | 245 | 71 | 5 | 35652658 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 20153263 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 21726816 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 16227571 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 12665591 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 18054859 | ||
| Pubmed | 2.13e-04 | 417 | 71 | 6 | 36537216 | ||
| Pubmed | 2.18e-04 | 419 | 71 | 6 | 15635413 | ||
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 2.23e-04 | 11 | 71 | 2 | 20351715 | |
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 24367103 | ||
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 2.23e-04 | 11 | 71 | 2 | 26689747 | |
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 20471949 | ||
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 2.27e-04 | 145 | 71 | 4 | 27049334 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.36e-04 | 605 | 71 | 7 | 28977666 | |
| Pubmed | 2.40e-04 | 808 | 71 | 8 | 20412781 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 2.58e-04 | 150 | 71 | 4 | 22678362 | |
| Pubmed | Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes. | 2.68e-04 | 12 | 71 | 2 | 23210685 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 2.68e-04 | 12 | 71 | 2 | 9624153 | |
| Pubmed | The little elongation complex regulates small nuclear RNA transcription. | 2.68e-04 | 12 | 71 | 2 | 22195968 | |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 2.68e-04 | 12 | 71 | 2 | 22650316 | |
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 20018852 | ||
| Interaction | H3-3A interactions | PHF2 BRIP1 BBX ARID4B ATRX VEZF1 RALBP1 HPF1 H1-3 SMARCB1 MSL1 USP39 HERC2 TOP2B AFF4 PRDM2 NCBP3 | 5.12e-10 | 749 | 70 | 17 | int:H3-3A |
| Interaction | H3C3 interactions | PHF2 BRIP1 MIS18BP1 BBX ATRX VEZF1 PES1 SMARCB1 MSL1 USP39 TOP2B AFF4 PRDM2 NCBP3 | 1.33e-09 | 495 | 70 | 14 | int:H3C3 |
| Interaction | H3C1 interactions | TNRC18 BRIP1 BBX ARID4B ANK3 ATRX RSL1D1 RALBP1 PES1 HPF1 H1-3 MLLT1 MSL1 USP39 TOP2B AFF4 PRDM2 | 8.27e-09 | 901 | 70 | 17 | int:H3C1 |
| Interaction | H1-3 interactions | 6.24e-08 | 291 | 70 | 10 | int:H1-3 | |
| Interaction | H2BC21 interactions | PHF2 ILF3 ARID4B ATRX PCLO HPF1 H1-3 SMARCB1 MLLT1 MSL1 DDX60L TOP2B PRDM2 MSL2 | 9.73e-08 | 696 | 70 | 14 | int:H2BC21 |
| Interaction | NUP43 interactions | PHF2 CASP8AP2 BRIP1 MIS18BP1 BBX ARID4B RSL1D1 MSL1 ASXL2 TOP2B PRDM2 NCBP3 MSL2 | 2.03e-07 | 625 | 70 | 13 | int:NUP43 |
| Interaction | H1-4 interactions | TNRC18 ILF3 BBX CEBPB RSL1D1 RALBP1 PPFIA1 H1-3 MSL1 ASXL2 NCAPH MNDA TOP2B | 3.52e-07 | 656 | 70 | 13 | int:H1-4 |
| Interaction | ZNF330 interactions | PHF2 ILF3 BBX ARID4B RSL1D1 PES1 MLLT1 MSL1 TOP2B AFF4 NCBP3 | 3.69e-07 | 446 | 70 | 11 | int:ZNF330 |
| Interaction | PARP1 interactions | PHF2 ILF3 BBX CEBPB ARID4B SACS RSL1D1 PES1 HPF1 H1-3 SMARCB1 MLLT1 MSL1 ASXL2 NCAPH TOP2B AFF4 PRDM2 | 3.71e-07 | 1316 | 70 | 18 | int:PARP1 |
| Interaction | H1-5 interactions | CEBPB RSL1D1 CNTRL HPF1 H1-3 MLLT1 MSL1 REPS2 NCAPH USP16 AFF4 | 5.34e-07 | 463 | 70 | 11 | int:H1-5 |
| Interaction | POLR1G interactions | PHF2 BBX CEBPB ARID4B RSL1D1 PES1 MLLT1 TOP2B AFF4 PRDM2 NCBP3 | 9.13e-07 | 489 | 70 | 11 | int:POLR1G |
| Interaction | H2AC20 interactions | 1.59e-06 | 320 | 70 | 9 | int:H2AC20 | |
| Interaction | HMGA1 interactions | 1.77e-06 | 419 | 70 | 10 | int:HMGA1 | |
| Interaction | SUZ12 interactions | PHF2 ILF3 CEBPB DPPA4 RSL1D1 PES1 H1-3 SMARCB1 ASXL2 NCAPH USP16 NCBP3 | 2.00e-06 | 644 | 70 | 12 | int:SUZ12 |
| Interaction | H1-2 interactions | H1-8 ILF3 CEBPB ATRX RSL1D1 VPS4A CNTRL H1-3 MSL1 ASXL2 NCAPH MNDA | 2.83e-06 | 666 | 70 | 12 | int:H1-2 |
| Interaction | H2BC9 interactions | 3.09e-06 | 446 | 70 | 10 | int:H2BC9 | |
| Interaction | NOP56 interactions | 4.02e-06 | 570 | 70 | 11 | int:NOP56 | |
| Interaction | MLLT1 interactions | 4.36e-06 | 123 | 70 | 6 | int:MLLT1 | |
| Interaction | H2AZ1 interactions | 5.33e-06 | 371 | 70 | 9 | int:H2AZ1 | |
| Interaction | CENPA interactions | 6.06e-06 | 377 | 70 | 9 | int:CENPA | |
| Interaction | LMNB1 interactions | STIM2 ILF3 CEBPB ATRX RSL1D1 PES1 H1-3 SMARCB1 HERC2 ZNF598 NCAPH | 7.64e-06 | 610 | 70 | 11 | int:LMNB1 |
| Interaction | PAF1 interactions | 9.38e-06 | 214 | 70 | 7 | int:PAF1 | |
| Interaction | MLLT3 interactions | 1.16e-05 | 85 | 70 | 5 | int:MLLT3 | |
| Interaction | CDK8 interactions | 1.19e-05 | 222 | 70 | 7 | int:CDK8 | |
| Interaction | ERC2 interactions | 1.35e-05 | 42 | 70 | 4 | int:ERC2 | |
| Interaction | RPL22 interactions | 2.08e-05 | 440 | 70 | 9 | int:RPL22 | |
| Interaction | PSMD1 interactions | 2.15e-05 | 442 | 70 | 9 | int:PSMD1 | |
| Interaction | SUPT16H interactions | 2.15e-05 | 442 | 70 | 9 | int:SUPT16H | |
| Interaction | H3-4 interactions | 2.39e-05 | 448 | 70 | 9 | int:H3-4 | |
| Interaction | CAPRIN1 interactions | 2.52e-05 | 451 | 70 | 9 | int:CAPRIN1 | |
| Interaction | PPL interactions | 3.05e-05 | 173 | 70 | 6 | int:PPL | |
| Interaction | SMC5 interactions | PHF2 BRIP1 ILF3 BBX ARID4B ATRX VEZF1 RSL1D1 MLLT1 MSL1 TOP2B AFF4 NCBP3 | 3.48e-05 | 1000 | 70 | 13 | int:SMC5 |
| Interaction | CAST interactions | 3.86e-05 | 109 | 70 | 5 | int:CAST | |
| Interaction | LDOC1 interactions | 4.79e-05 | 114 | 70 | 5 | int:LDOC1 | |
| Interaction | NSD1 interactions | 5.88e-05 | 119 | 70 | 5 | int:NSD1 | |
| Interaction | CAVIN1 interactions | 6.85e-05 | 292 | 70 | 7 | int:CAVIN1 | |
| Interaction | EAF1 interactions | 8.31e-05 | 128 | 70 | 5 | int:EAF1 | |
| Interaction | PSMD14 interactions | 8.41e-05 | 527 | 70 | 9 | int:PSMD14 | |
| Interaction | RPS24 interactions | 8.66e-05 | 529 | 70 | 9 | int:RPS24 | |
| Interaction | AGAP2 interactions | 8.97e-05 | 210 | 70 | 6 | int:AGAP2 | |
| Interaction | H2BC13 interactions | 8.97e-05 | 210 | 70 | 6 | int:H2BC13 | |
| Interaction | HDAC1 interactions | CASP8AP2 NRIP1 TNRC18 BBX CEBPB ARID4B ATRX RALBP1 PPFIA1 SMARCB1 INPP5F NCAPH TOP2B | 9.94e-05 | 1108 | 70 | 13 | int:HDAC1 |
| Interaction | RPL7A interactions | 1.13e-04 | 679 | 70 | 10 | int:RPL7A | |
| Interaction | RPL31 interactions | 1.14e-04 | 680 | 70 | 10 | int:RPL31 | |
| Interaction | NUCKS1 interactions | 1.16e-04 | 220 | 70 | 6 | int:NUCKS1 | |
| Interaction | NIFK interactions | 1.21e-04 | 431 | 70 | 8 | int:NIFK | |
| Interaction | ERG interactions | 1.25e-04 | 223 | 70 | 6 | int:ERG | |
| Interaction | H2BC12 interactions | 1.26e-04 | 322 | 70 | 7 | int:H2BC12 | |
| Interaction | TOP1 interactions | ILF3 CEBPB ARID4B VEZF1 RALBP1 PES1 SMARCB1 USP39 HERC2 TOP2B | 1.38e-04 | 696 | 70 | 10 | int:TOP1 |
| Interaction | SEPTIN7 interactions | 1.41e-04 | 228 | 70 | 6 | int:SEPTIN7 | |
| Interaction | PRPF40A interactions | 1.54e-04 | 446 | 70 | 8 | int:PRPF40A | |
| Interaction | H2BC8 interactions | 1.65e-04 | 576 | 70 | 9 | int:H2BC8 | |
| Interaction | USP16 interactions | 1.65e-04 | 79 | 70 | 4 | int:USP16 | |
| Interaction | UPF1 interactions | 1.76e-04 | 581 | 70 | 9 | int:UPF1 | |
| Interaction | GLYR1 interactions | 1.82e-04 | 239 | 70 | 6 | int:GLYR1 | |
| Interaction | H4C16 interactions | 1.86e-04 | 152 | 70 | 5 | int:H4C16 | |
| Interaction | RRS1 interactions | 1.93e-04 | 345 | 70 | 7 | int:RRS1 | |
| Interaction | CDK1 interactions | 1.97e-04 | 590 | 70 | 9 | int:CDK1 | |
| Interaction | RPS6 interactions | PHF2 H1-8 ILF3 BBX CEBPB RSL1D1 PCLO PES1 ZNF598 NCAPH TOP2B | 1.99e-04 | 874 | 70 | 11 | int:RPS6 |
| Interaction | ASF1A interactions | 2.27e-04 | 249 | 70 | 6 | int:ASF1A | |
| Interaction | PPIA interactions | BRIP1 ILF3 BBX CEBPB ANK3 MLLT1 ASXL2 ZNF598 USP16 ERBIN NCBP3 | 2.29e-04 | 888 | 70 | 11 | int:PPIA |
| Interaction | MSL3 interactions | 2.43e-04 | 35 | 70 | 3 | int:MSL3 | |
| Interaction | MYH10 interactions | 2.46e-04 | 359 | 70 | 7 | int:MYH10 | |
| Interaction | PUM3 interactions | 2.52e-04 | 254 | 70 | 6 | int:PUM3 | |
| Interaction | DDX23 interactions | 2.53e-04 | 480 | 70 | 8 | int:DDX23 | |
| Interaction | PES1 interactions | 2.74e-04 | 258 | 70 | 6 | int:PES1 | |
| Interaction | RRP8 interactions | 2.80e-04 | 259 | 70 | 6 | int:RRP8 | |
| Interaction | PICK1 interactions | 2.90e-04 | 490 | 70 | 8 | int:PICK1 | |
| Interaction | TNRC18 interactions | 2.96e-04 | 92 | 70 | 4 | int:TNRC18 | |
| Interaction | CEBPA interactions | PHF2 TNRC18 ILF3 CEBPB VEZF1 RSL1D1 PES1 SMARCB1 ASXL2 USP39 MNDA TOP2B PRDM2 | 3.14e-04 | 1245 | 70 | 13 | int:CEBPA |
| Interaction | AATF interactions | 3.25e-04 | 376 | 70 | 7 | int:AATF | |
| Interaction | SNRNP40 interactions | 3.47e-04 | 637 | 70 | 9 | int:SNRNP40 | |
| Interaction | CHD4 interactions | ILF3 CEBPB VEZF1 RSL1D1 PES1 SMARCB1 USP39 ZNF598 NCAPH TOP2B NCBP3 | 3.65e-04 | 938 | 70 | 11 | int:CHD4 |
| Interaction | TXLNG interactions | 3.77e-04 | 98 | 70 | 4 | int:TXLNG | |
| Interaction | ANK2 interactions | 3.77e-04 | 98 | 70 | 4 | int:ANK2 | |
| Interaction | CBX3 interactions | 3.84e-04 | 646 | 70 | 9 | int:CBX3 | |
| Interaction | ABR interactions | 3.89e-04 | 41 | 70 | 3 | int:ABR | |
| Interaction | GRWD1 interactions | 4.05e-04 | 390 | 70 | 7 | int:GRWD1 | |
| Interaction | TRIM8 interactions | 4.07e-04 | 100 | 70 | 4 | int:TRIM8 | |
| Interaction | NCL interactions | 4.13e-04 | 798 | 70 | 10 | int:NCL | |
| Interaction | H1-10 interactions | 4.24e-04 | 280 | 70 | 6 | int:H1-10 | |
| Interaction | ARPC3 interactions | 4.39e-04 | 183 | 70 | 5 | int:ARPC3 | |
| Interaction | ING1 interactions | 4.55e-04 | 103 | 70 | 4 | int:ING1 | |
| Interaction | NAA40 interactions | ILF3 ATRX RSL1D1 CLMN PES1 ZNF598 NCAPH USP16 ERBIN TOP2B AFF4 | 5.19e-04 | 978 | 70 | 11 | int:NAA40 |
| Interaction | ABRACL interactions | 5.26e-04 | 10 | 70 | 2 | int:ABRACL | |
| Interaction | YWHAZ interactions | STIM2 CEBPB PPFIA2 PPFIA1 LPIN2 SMARCB1 CNKSR2 ASXL2 INPP5F HERC2 ZNF598 ERBIN MSL2 | 5.45e-04 | 1319 | 70 | 13 | int:YWHAZ |
| Interaction | NUPR1 interactions | 5.74e-04 | 683 | 70 | 9 | int:NUPR1 | |
| Interaction | KPNB1 interactions | 5.81e-04 | 544 | 70 | 8 | int:KPNB1 | |
| Interaction | BRIX1 interactions | 6.10e-04 | 300 | 70 | 6 | int:BRIX1 | |
| Interaction | COIL interactions | 6.40e-04 | 552 | 70 | 8 | int:COIL | |
| Interaction | ANKRD24 interactions | 6.41e-04 | 11 | 70 | 2 | int:ANKRD24 | |
| Interaction | CREBL2 interactions | 6.41e-04 | 11 | 70 | 2 | int:CREBL2 | |
| Interaction | H3-5 interactions | 6.68e-04 | 114 | 70 | 4 | int:H3-5 | |
| Interaction | ZNF22 interactions | 6.68e-04 | 114 | 70 | 4 | int:ZNF22 | |
| Interaction | MMS19 interactions | 7.37e-04 | 311 | 70 | 6 | int:MMS19 | |
| Interaction | MLLT10 interactions | 7.42e-04 | 51 | 70 | 3 | int:MLLT10 | |
| Interaction | SCARNA22 interactions | 7.60e-04 | 118 | 70 | 4 | int:SCARNA22 | |
| Interaction | CHL1 interactions | 7.67e-04 | 12 | 70 | 2 | int:CHL1 | |
| Interaction | MTA2 interactions | 7.73e-04 | 435 | 70 | 7 | int:MTA2 | |
| Interaction | HDAC2 interactions | NRIP1 ILF3 CEBPB ARID4B H1-3 SMARCB1 HERC2 ZNF598 NCAPH TOP2B | 7.73e-04 | 865 | 70 | 10 | int:HDAC2 |
| Cytoband | 15q21.2 | 9.32e-04 | 29 | 71 | 2 | 15q21.2 | |
| GeneFamily | Sterile alpha motif domain containing | 2.55e-06 | 88 | 45 | 5 | 760 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.16e-04 | 9 | 45 | 2 | 1280 | |
| GeneFamily | Ubiquitin specific peptidases | 3.64e-04 | 56 | 45 | 3 | 366 | |
| GeneFamily | PDZ domain containing | 6.38e-03 | 152 | 45 | 3 | 1220 | |
| Coexpression | GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN | 1.08e-06 | 197 | 71 | 7 | M7696 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 1.52e-05 | 541 | 71 | 9 | MM1061 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP | 1.69e-05 | 199 | 71 | 6 | M6412 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | 3.12e-05 | 454 | 71 | 8 | M19927 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | STIM2 SAMD9L MIS18BP1 BBX ARID4B ATRX VEZF1 SACS CNTRL LPIN2 ASXL2 ERBIN TOP2B PRDM2 | 3.99e-05 | 1492 | 71 | 14 | M40023 |
| Coexpression | PILON_KLF1_TARGETS_UP | 6.41e-05 | 503 | 71 | 8 | M2226 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 6.81e-05 | 656 | 71 | 9 | M18979 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 7.98e-05 | 519 | 71 | 8 | M3395 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 8.91e-05 | 166 | 71 | 5 | M6826 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.09e-04 | 543 | 71 | 8 | MM997 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | 1.30e-04 | 714 | 71 | 9 | M1744 | |
| Coexpression | E2F1_UP.V1_UP | 1.60e-04 | 188 | 71 | 5 | M2632 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 1.85e-04 | 194 | 71 | 5 | M7313 | |
| Coexpression | EGFR_UP.V1_DN | 1.94e-04 | 196 | 71 | 5 | M2633 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP | 2.08e-04 | 199 | 71 | 5 | M7712 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP | 2.08e-04 | 199 | 71 | 5 | M8744 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 2.13e-04 | 200 | 71 | 5 | M8030 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 2.13e-04 | 200 | 71 | 5 | M8090 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 2.13e-04 | 200 | 71 | 5 | M6249 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 2.13e-04 | 200 | 71 | 5 | M8997 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 2.13e-04 | 200 | 71 | 5 | M3580 | |
| Coexpression | GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN | 2.13e-04 | 200 | 71 | 5 | M3491 | |
| Coexpression | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP | 2.46e-04 | 112 | 71 | 4 | M4939 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | PKNOX2 CASP8AP2 MIS18BP1 ARID4B ANK3 ATRX RSL1D1 CNTRL HPF1 FGF7 CNKSR2 STIL NCAPH USP16 ERBIN TOP2B | 1.70e-06 | 1241 | 69 | 16 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | PKNOX2 CASP8AP2 MIS18BP1 ARID4B ATRX RSL1D1 VPS4A CNTRL CNKSR2 ASXL2 STIL NCAPH CFAP97 ZFP37 TOP2B | 9.27e-06 | 1252 | 69 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | PKNOX2 CASP8AP2 MIS18BP1 ARID4B ANK3 ATRX RSL1D1 CNTRL HPF1 FGF7 CNKSR2 STIL NCAPH USP16 ERBIN TOP2B | 1.45e-05 | 1468 | 69 | 16 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.10e-05 | 173 | 69 | 6 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.08e-05 | 275 | 69 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | USP45 MIS18BP1 ZC2HC1A ATRX VPS4A PPFIA1 ERBIN CFAP97 ZFP37 TOP2B AFF4 | 4.00e-05 | 780 | 69 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | PKNOX2 CASP8AP2 MIS18BP1 ARID4B ATRX VEZF1 PPFIA2 CNTRL GSTCD LPIN2 STIL NCAPH ZFP37 TOP2B | 1.10e-04 | 1370 | 69 | 14 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.13e-04 | 146 | 69 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.15e-04 | 339 | 69 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.62e-04 | 84 | 69 | 4 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.93e-04 | 369 | 69 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.13e-04 | 375 | 69 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.21e-04 | 91 | 69 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NRIP1 TNRC18 MIS18BP1 ZC2HC1A ATRX CLMN INPP5F CFAP97 ZFP37 NCBP3 | 2.50e-04 | 801 | 69 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NRIP1 USP45 MIS18BP1 ATRX DPPA4 CLMN ASXL2 CFAP97 ZFP37 NCBP3 | 2.58e-04 | 804 | 69 | 10 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | PKNOX2 NRIP1 TNRC18 MIS18BP1 BBX ATRX DPPA4 CLMN RALBP1 CFAP97 | 2.63e-04 | 806 | 69 | 10 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.81e-04 | 277 | 69 | 6 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 4.23e-04 | 194 | 69 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-08 | 191 | 71 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-08 | 191 | 71 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-08 | 191 | 71 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.12e-08 | 199 | 71 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.12e-08 | 199 | 71 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-07 | 182 | 71 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 5.11e-07 | 185 | 71 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 185 | 71 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.60e-07 | 198 | 71 | 6 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.60e-07 | 198 | 71 | 6 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 7.60e-07 | 198 | 71 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 7.83e-07 | 199 | 71 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 7.83e-07 | 199 | 71 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.83e-07 | 199 | 71 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.83e-07 | 199 | 71 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 8.06e-07 | 200 | 71 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.06e-07 | 200 | 71 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-06 | 169 | 71 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.14e-06 | 176 | 71 | 5 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.14e-06 | 176 | 71 | 5 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 176 | 71 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-06 | 178 | 71 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 182 | 71 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 182 | 71 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.10e-05 | 183 | 71 | 5 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 71 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-05 | 185 | 71 | 5 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.19e-05 | 186 | 71 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 187 | 71 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 1.26e-05 | 188 | 71 | 5 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.43e-05 | 193 | 71 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 193 | 71 | 5 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | Control-B_memory-0|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.43e-05 | 193 | 71 | 5 | b8d64cc0abc4a3311e172e7e48a7de0f2188effb | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 194 | 71 | 5 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-05 | 195 | 71 | 5 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.50e-05 | 195 | 71 | 5 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.58e-05 | 197 | 71 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-05 | 197 | 71 | 5 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.61e-05 | 198 | 71 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-05 | 198 | 71 | 5 | 93cc01d91ffc543fd1a717ef47e02e532b50b665 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 198 | 71 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 1.65e-05 | 199 | 71 | 5 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 1.65e-05 | 199 | 71 | 5 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.65e-05 | 199 | 71 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.65e-05 | 199 | 71 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.65e-05 | 199 | 71 | 5 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 1.65e-05 | 199 | 71 | 5 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 1.65e-05 | 199 | 71 | 5 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.65e-05 | 199 | 71 | 5 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.65e-05 | 199 | 71 | 5 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.69e-05 | 200 | 71 | 5 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.69e-05 | 200 | 71 | 5 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.69e-05 | 200 | 71 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 7.02e-05 | 138 | 71 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-STAT1+_Naive_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 152 | 71 | 4 | dd728aa3ffdb2c415730a62678f69cf0e8af09df | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 1.02e-04 | 152 | 71 | 4 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 156 | 71 | 4 | a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 157 | 71 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 163 | 71 | 4 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-04 | 166 | 71 | 4 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | COVID-19_Severe-CD4+_T_activated|COVID-19_Severe / Disease condition and Cell class | 1.43e-04 | 166 | 71 | 4 | 0f138dbafad6f83975944e8f6398411127b150cc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 167 | 71 | 4 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 167 | 71 | 4 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.50e-04 | 168 | 71 | 4 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 169 | 71 | 4 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 169 | 71 | 4 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 169 | 71 | 4 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-04 | 169 | 71 | 4 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 171 | 71 | 4 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 171 | 71 | 4 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-04 | 173 | 71 | 4 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.75e-04 | 175 | 71 | 4 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 1.75e-04 | 175 | 71 | 4 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 177 | 71 | 4 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.91e-04 | 179 | 71 | 4 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-04 | 179 | 71 | 4 | e1bfd553c043ebc070ccf8545d489ba16d9b2ef4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-04 | 179 | 71 | 4 | dc0b806904ef4c2f74f34ade2b1c0d6893f3b2ec | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 180 | 71 | 4 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.99e-04 | 181 | 71 | 4 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.99e-04 | 181 | 71 | 4 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 182 | 71 | 4 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.04e-04 | 182 | 71 | 4 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-04 | 182 | 71 | 4 | c6b3762ccec326f057819f75fa7fac0145fb7d54 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 2.04e-04 | 182 | 71 | 4 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.04e-04 | 182 | 71 | 4 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-04 | 182 | 71 | 4 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-04 | 182 | 71 | 4 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 2.08e-04 | 183 | 71 | 4 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 183 | 71 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.08e-04 | 183 | 71 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.08e-04 | 183 | 71 | 4 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 183 | 71 | 4 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 184 | 71 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 184 | 71 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 184 | 71 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 184 | 71 | 4 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.17e-04 | 185 | 71 | 4 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 8.22e-08 | 183 | 69 | 8 | 7498_DN | |
| Drug | Antigens, Polyomavirus Transforming | PHF2 TNRC18 MIS18BP1 ANK3 CNTRL MLLT1 FGF7 ZNF598 NCAPH PRDM2 NCBP3 | 4.96e-06 | 668 | 69 | 11 | ctd:D000952 |
| Drug | triisopropanolamine | 9.05e-06 | 2 | 69 | 2 | CID000024730 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.67e-05 | 178 | 69 | 6 | 3998_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.73e-05 | 179 | 69 | 6 | 4585_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.35e-05 | 189 | 69 | 6 | 4271_DN | |
| Disease | meningioma (is_implicated_in) | 8.27e-05 | 6 | 70 | 2 | DOID:3565 (is_implicated_in) | |
| Disease | thyroid volume | 6.52e-04 | 16 | 70 | 2 | EFO_0004865 | |
| Disease | cervical squamous cell carcinoma (is_marker_for) | 1.24e-03 | 22 | 70 | 2 | DOID:3744 (is_marker_for) | |
| Disease | Adenoid Cystic Carcinoma | 1.75e-03 | 100 | 70 | 3 | C0010606 | |
| Disease | gamma-glutamyltyrosine measurement | 1.87e-03 | 27 | 70 | 2 | EFO_0021144 | |
| Disease | hormone measurement, thyroid stimulating hormone measurement | 2.16e-03 | 29 | 70 | 2 | EFO_0004730, EFO_0004748 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKATVVNNKKKGKGT | 1136 | Q4LE39 | |
| TTIHGSKKAPAKSVK | 311 | Q96M60 | |
| AKKLEKKHPQTSSSG | 1206 | Q96RT1 | |
| KDPKHSHMKAQKSGK | 546 | Q7Z7A1 | |
| HVKSKSAKPSTNVKK | 146 | Q9P2B7 | |
| RHGNDKSTPKKTCKK | 461 | Q8WY36 | |
| HGRTSKLKPKVKEKS | 216 | Q14330 | |
| KGSKVLCPKKKAEHT | 56 | Q7L190 | |
| NTEAHQKKASKKKAP | 1871 | Q9UKL3 | |
| AGKVISPSQKHSKKA | 151 | Q76L83 | |
| HKAATKGSRKPNIKK | 601 | Q9UHB7 | |
| VGNVPLKKAKESKKH | 526 | Q76M96 | |
| SKGIHVFKKPSFSKK | 106 | Q15311 | |
| ILAGKHKTKKKSTGL | 86 | Q9NWY4 | |
| PKNTKFGKSKHKQST | 686 | Q8N7Z5 | |
| ATGSFKLVPKHKKKI | 121 | Q8IZA3 | |
| KNGAASPTKKKVVAK | 271 | Q8IZA3 | |
| SQKHVTKKKPANSKG | 931 | Q6P0N0 | |
| KHKIKKSTKQAFAGQ | 2296 | O95714 | |
| KADTKKKGATLPQHI | 346 | Q9UBK8 | |
| TKPHQITKKSKKKSF | 561 | Q5H9U9 | |
| KKHGSSKPTDGTKVV | 4676 | Q9Y6V0 | |
| SAPKTKEKNTKKVDH | 551 | Q53F19 | |
| QDSLHKAPKKKGIKS | 791 | Q13136 | |
| KKKGHKNNVTNSKPE | 961 | P48552 | |
| TKKKKINHGANPETT | 36 | A0A1B0GV03 | |
| FSKVKTKTPKHSPIK | 351 | Q68DK7 | |
| SKKSHSKTKPGILKK | 416 | Q9HCI7 | |
| HTTTKKEKQPKKAEG | 311 | Q9BY11 | |
| NTIKKDHTGKSKIPK | 231 | Q9BX63 | |
| SKHLKTKTCKKVQDG | 946 | P46100 | |
| AIHSPGTVEKEAKKK | 176 | Q96C57 | |
| PSQVKSKAKKTVDKH | 256 | P17676 | |
| SGPSKKTAKLHVAVK | 446 | Q12906 | |
| KQSTKETLKPKIHGS | 4276 | Q12955 | |
| KAKTKNVSVTPGHKK | 456 | Q96QF7 | |
| KESSKTSKPHKVTKE | 186 | Q03111 | |
| KVAGAATPKKSIKKT | 141 | P16402 | |
| GKKTKKEQKTAHFLP | 176 | P21781 | |
| HIKSNVSAPNKKKVK | 136 | Q9Y2H2 | |
| HKTSSKHQSPKKLKV | 4286 | Q9NZJ4 | |
| PLTKGKAKSKVHTQE | 211 | Q8NEC7 | |
| KKSKNKRGVLPKHAT | 286 | Q96KN3 | |
| SSQDSLHKAPKKKGI | 816 | O75334 | |
| PKKKVSHSSKKGGHS | 1486 | Q13029 | |
| GSHSFIKVIKAKKNK | 386 | P41218 | |
| PNCEKTHGKSTLKKK | 51 | O75151 | |
| GKSKATPEKSLHDKK | 1426 | Q02880 | |
| HSALGGTKKKKKTIV | 331 | Q53GS9 | |
| SKTEHQKNPKHTKKE | 96 | Q8IVG5 | |
| KKIVASSHGKKTKPN | 61 | Q12824 | |
| GKRSIKSAHKKKDSP | 606 | Q96JQ2 | |
| KSAHKKKDSPEPQVK | 611 | Q96JQ2 | |
| GTTKKAVKPKKKHLH | 206 | Q15003 | |
| SSLQHKSKKKNKGPI | 541 | Q8WXI2 | |
| HEGVTSPKSKKAKEA | 2466 | O15417 | |
| KQCVAVHTGKKSKKT | 241 | Q8N587 | |
| GVKIDSPTKVKKNAH | 1006 | Q15468 | |
| SEHNTKKKNVPGLKA | 761 | Q70EL2 | |
| QSVKKPSKPVKKNHA | 161 | Q14119 | |
| HPDLVQKAKKSSVSK | 171 | P0CB47 | |
| IPSGTSKHLQKKAKK | 431 | Q9Y5T5 | |
| HEPKHKKKVNKGSTA | 46 | O00541 | |
| KPHPTVQKQSSKQKK | 596 | Q8NFH8 | |
| VEIQKHATGKKSPAK | 381 | O76021 | |
| HNGEKSKKPSKIKSL | 726 | Q9P246 | |
| HSNLIKGVSKEVKKP | 466 | O95427 | |
| KGKQPTTAEKSATKK | 16 | Q8N7R0 | |
| LKKHGPICQKTATKK | 31 | Q96GY0 | |
| SIQPSKVGKKKKVGS | 581 | Q86UK7 | |
| KKEHSVPSDKQVKAK | 411 | Q13061 | |
| KGKKQTGKKHEKLSS | 221 | Q9Y6Q3 | |
| SKEKHGKKPVKENQS | 76 | Q9UN37 | |
| KVDSPSKKKGVHKRS | 381 | Q92539 |